AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Jun 29, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2004.060152v1
96/8/1354    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Des Jarlais, D. C.
Right arrow Articles by Braine, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Des Jarlais, D. C.
Right arrow Articles by Braine, N.
Related Collections
Right arrow HIV/AIDS
Right arrow Prevention
Right arrow Drugs
August 2006, Vol 96, No. 8 | American Journal of Public Health 1354-1358
© 2006 American Public Health Association
DOI: 10.2105/AJPH.2004.060152


HEALTH POLICY AND ETHICS

Diffusion of the D.A.R.E and Syringe Exchange Programs

Don C. Des Jarlais, PhD, Zili Sloboda, PhD, Samuel R. Friedman, PhD, Barbara Tempalski, PhD, Courtney McKnight, MPH and Naomi Braine, PhD

Don C. Des Jarlais, Courtney McKnight, and Naomi Braine are with the Beth Israel Medical Center, New York, NY. Zili Sloboda is with the Institute for Health and Social Policy, University of Akron, Ohio. Samuel R. Friedman and Barbara Tempalski are with the National Development and Research Institutes, New York, NY.

Correspondence: Requests for reprints should be sent to Don Des Jarlais, Beth Israel Medical Center, 160 Water Street, 24th Floor, New York, NY 10038 (e-mail: dcdesjarla{at}aol.com).

ABSTRACT

We examined the diffusion of the D.A.R.E program to reduce use of illicit drugs among school-aged children and youths and the diffusion of syringe exchange programs to reduce HIV transmission among injection drug users. The D.A.R.E program was diffused widely in the United States despite a lack of evidence for its effectiveness; there has been limited diffusion of syringe exchange in the United States, despite extensive scientific evidence for its effectiveness.

Multiple possible associations between diffusion and evidence of effectiveness exist, from widespread diffusion without evidence of effectiveness to limited diffusion with strong evidence of effectiveness. The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations.




This article has been cited by other articles:


Home page
CMAJHome page
E. Wood MD PhD and T. Kerr PhD
Methamphetamine strategy requires evaluation
Can. Med. Assoc. J., September 23, 2008; 179(7): 677 - 677.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Public Health Association